Institutional Analyst Inc. Initiates Coverage on Vystar’s Vytex Better Cleaner Latex Atlanta – March 22, 2017 – Institutional Analyst Inc. has initiated coverage of Vystar Corp., (OTC PINK: VYST), with a report in “Biotech Stock Review” detailing the market opportunity for Vystar as the exclusive creator and licensor of breakthrough patented processes that remove virtually all proteins and non-rubbers that cause latex allergies and odor from latex to create Vytex ® natural rubber latex (NRL) that can be used in over 40,000… Read More »

Institutional Analyst Inc. has initiated coverage of Vystar Corp., (VYST), with a report in “Biotech Stock Review” detailing the market opportunity for Vystar as the exclusive creator and licensor of breakthrough patented processes that remove virtually all proteins and non-rubbers that cause latex allergies and odor from latex to create Vytex ® natural rubber latex (NRL) that can be used in over 40,000 products. Download the full Report in PDF Format (9MB).

“New to the Street” host Ken Evseroff interviews Vystar CEO Bill Doyle, NHS and Rotmans Furniture CEO Steve Rotman and Hedge Fund Manager and Medical Doctor Joseph Allegra. They explore how Vytex is replacing materials that are non-biodegradable, have harmful off gassing, cause allergies or have noxious smells in 40,000 different products with a superior, yet budget-friendly alternative to traditional latex, memory foam, and other petrochemical-based materials. The segment aired on ION TV in New York on 3/20.

Natural Rubber Latex (NRL) is a constant and preferred raw material for latex end product manufacturers around the globe with its ready availability, ease of processing, and the excellent performance of latex end products in critical environments. However, the presence of non- rubbers, especially certain allergenic proteins, has inhibited its continued use in several existing products and entry into new applications. The introduction of Vytex, which uses specially treated process, to target the surface and bound proteins of both the… Read More »

Vytex®, harvested from the Hevea brasiliensis tree, has transformed ordinary latex using a patented process for the production of an ultra low antigenic protein natural rubber latex raw material. The science and applied technology behind its creation is multi-faceted and includes the use of insoluble aluminum hydroxide (Al(OH)3), well known for its protein binding characteristics, in a proprietary blend. The colloidal and physical properties of this Al(OH)3 treated latex are presented and compared with standard CL60 lattices. Extensive field, laboratory… Read More »

A major responsibility of manufacturing and/or marketing personnel is finding innovative techniques to differentiate their products vs. competition while driving down costs. Vytex was created to lessen the protein load in natural rubber latex for medical products, but has shown unique competitive advantages due to its versatility as a raw material regardless of end product application. The result of that extensive research led to, not only a nearly total protein reduction, but an overall 75% drop in non-rubber content, as… Read More »

Vytex is a new product designed to offer a standardized source material for the production of natural rubber products using chemically modified NRL to significantly reduce its antigenic protein content. Vytex is commercially available and has significantly reduced in antigenic proteins and can be used in a wide array of commercial applications.

The true cost of manufacturing is measured as the sum of the total costs throughout the production cycle. Sometimes more can be less. Water and energy stress caused by the growing global population is expected to reach historic proportions, driving supply down and costs up, and directly affecting business operations according to a recent United Nations report.

DURHAM, NC and ATLANTA, GA–(Marketwired – Jun 6, 2016) – Vystar Corp. (OTC PINK: VYST) has closed its Kiron Sleep Lab LLC division in Durham, NC in order to focus on its core business of Vytex® environmentally friendly, ultra low protein natural rubber latex commodities and licensing business.

ATLANTA, GA–(Marketwired – May 18, 2016) – Vystar Corporation (OTC PINK: VYST) has named Keith D. Osborn, MD, to its Board of Directors, effective immediately. “We welcome Keith’s analytical and strategic insight as he transitions from a long-time, very engaged investor to even greater involvement as a member of our Board of Directors,” stated William Doyle, Vystar CEO. “Over the years, Keith has always provided a calm, introspective and forward thinking thought process and worked closely with us as we… Read More »